Skip to main content
DOCS logo

Doximity, Inc. (DOCS) Stock: Price, Forecast & Analyst Target

Doximity, Inc. (DOCS) — MoonshotScore 95/100 (Exceptional band), calculated Nov 18, 2026. Price $29.61 (-3.46%), as of the Nov 19, 2026 trading session; market cap $5.28B. Expected results Feb 4, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$29.61 −$1.06 (-3.46%) Market Cap $5.28B

Doximity, Inc. · DOCS · NYSE · Healthcare · Medical - Healthcare Information Services

Research dated 2026-09-13: Doximity operates a cloud-hosted platform where physicians, hospital systems, and pharmaceutical companies connect to deliver patient care, share medical information, and conduct professional collaboration. The company monetizes via subscription fees from healthcare organizations and marketing services to pharmaceutical clients; the key question is whether platform adoption and pricing sustain against rising competition and valuation multiples.

Price as of Nov 19, 2026

Key Statistics

95 of 100

MoonshotScore v2 · Doximity (DOCS)

Exceptional
Business Quality Elite (94)
Financial Safety Fortress (96)
Valuation Full (47)
Growth Durability Growing (75)
Momentum Surging (82)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a fortress balance sheet and durable growth, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Full; Growth Durability: Growing; Momentum: Surging.

  • EPS beat 6 of the last 8 reports
  • Altman Z 23.36 · Piotroski F 6
  • ROE 14.8% · ROA 12.8% · current ratio 6.37 · earnings yield 2.4% · free-cash-flow yield 5.1%

Helping: business quality, balance-sheet strength, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for DOCS (57 recorded, newest six shown)
RecordedScoreBand
94Exceptional
95Exceptional
95Exceptional
95Exceptional
95Exceptional
95Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$29.61
Change on the day-3.46%
52-week range$17.15–$51.84
Market capitalisation$5.28B—
Price / earnings (trailing)41.48
Shares traded on the day2.02M
Beta (volatility vs the S&P 500)1.29

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $19, high $68, latest $30. 4 reported quarters marked, 2 above and 2 below the recorded estimate. $68 $19 high $68 Feb 5, 2026 · Earnings results · reported above the recorded estimate · close $281May 13, 2026 · Earnings results · reported below the recorded estimate · close $192Aug 6, 2026 · Earnings results · reported below the recorded estimate · close $273Nov 5, 2026 · Earnings results · reported above the recorded estimate · close $334 Oct 17, 2025 Nov 19, 2026 · $30 $68Oct 17, 2025$66Oct 31, 2025$50Nov 14, 2025$51Nov 28, 2025$44Dec 12, 2025$44Dec 26, 2025$44Jan 9, 2026$41Jan 23, 2026$28Feb 6, 2026$26Feb 20, 2026$25Mar 6, 2026$24Mar 20, 2026$23Apr 2, 2026$25Apr 17, 2026$25May 1, 2026$19May 15, 2026$21May 29, 2026$20Jun 12, 2026$21Jun 26, 2026$22Jul 10, 2026$20Jul 24, 2026$27Aug 7, 2026$25Aug 21, 2026$26Sep 4, 2026$26Sep 18, 2026$28Oct 2, 2026$31Oct 16, 2026$33Oct 30, 2026$33Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Doximity (DOCS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Neutral
Growth Durability Moderate
Momentum Strong

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Overvalued
Profit Margin Strong
Debt/Equity Strong
ROE Moderate
Gross Margin Strong

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 18, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Doximity (DOCS), and what does it report?

Short answer · as of

Doximity's core offering is membership in a professional network serving licensed U.S. practitioners.

Physicians access peer-to-peer messaging, remote consultation infrastructure, medical literature feeds, and career development tools at no direct cost; the company generates revenue by charging healthcare organizations for administrator accounts and data access, and by selling targeted marketing services to pharmaceutical companies. Operating cash flow reflects cash collected from these subscribers and services minus platform hosting, customer support, and sales expenses. The business model is durable because switching costs are high once adoption embeds clinical workflow.

2 · Latest results

What do the latest results show for Doximity (DOCS)?

The most recent quarter showed revenue that exceeded estimates while earnings per share fell slightly short of consensus expectations. Operating cash flow declined from the prior period despite revenue growth, suggesting either timing of cash receipts or higher working capital deployment. Subscription revenue—the majority of total revenue—expanded and represents the most predictable revenue stream. Margins remain elevated, though year-over-year expansion paused from the acceleration of the previous period.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$174.54M Nov 5, 2026
Latest report · revenue estimate
$170.84M Nov 5, 2026
Latest report · revenue vs estimate
Above estimate Nov 5, 2026
Latest report · EPS vs estimate
Above estimate Nov 5, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 5, 2026$174.54M$170.84M$0.3600$0.3483
Aug 6, 2026$156.62M$151.77M$0.2900$0.3030
May 13, 2026$145.37M$144.03M$0.2600$0.2800
Feb 5, 2026$185.05M$181.63M$0.4600$0.4400
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$169M$62M$0.31 (diluted)
Q3 FY2026$185M$62M$0.31 (diluted)
Q4 FY2026$145M$19M$0.10 (diluted)
Q1 FY2027$157M$24M$0.13 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Doximity (DOCS)?

Short answer · as of

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

The balance sheet stands as a fortress with cash that exceeds total debt by an enormous margin, no meaningful interest-bearing obligations, and current assets covering liabilities by a multiple. Operating margins of this magnitude are exceptional and reflect software economics and network effects. The principal financial risk is erosion of competitive moat—either through new entrants fragmenting the physician community or existing platforms (health systems, Microsoft, Amazon) adding physician collaboration features at negligible incremental cost. Valuation multiples suggest markets are pricing in strong competitive headwinds.

4 · What to check next?

What should you watch next at Doximity (DOCS)?

Short answer · as of

The next earnings report is expected on Feb 4, 2027.

Monitor subscription growth rates and pricing trends to confirm the core platform remains defensible. Watch for platform engagement metrics beyond the financial statements—monthly active users, message volume, time spent—to validate that network stickiness persists as the company matures. Recent analyst downgrades warrant attention as signals of consensus concern around growth deceleration or valuation exhaustion. Cash flow conversion remains the sanity check; if subscription revenue grows but cash collection slows, moat confidence should decline.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Doximity compare with its peers?

Short answer

Doximity's score ranks tied for 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Healthcare social platforms all compete for physician engagement and attention. Doximity's advantage rests on scale—largest physician network in the United States—and the installed base of health systems and pharma customers who have embedded its workflow into procurement and marketing processes. Newer competitors, particularly those backed by AWS or cloud infrastructure giants, carry lower friction cost structures but must build equivalent network density. This creates a race between Doximity's first-mover defensibility and the economics advantage of big tech entrants.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Hinge Health, Inc. (HNGE) Same industry, near in market value$114.53 Nov 18, 2026$9.31B97 5-pillar Nov 18, 2026
Doximity (DOCS) — this page$29.61$5.28B95
Progyny, Inc. (PGNY) Same industry, near in market value$35.45 Nov 19, 2026$2.61B95 5-pillar Nov 18, 2026
HealthEquity, Inc. (HQY) Same industry, near in market value$97.31 Nov 18, 2026$8.05B90 5-pillar Nov 18, 2026
BrightSpring Health Services, Inc. (BTSG) Same industry, near in market value$64.02 Nov 19, 2026$12.7B87 5-pillar Nov 18, 2026
Privia Health Group, Inc. (PRVA) Same industry, near in market value$24.69 Nov 19, 2026$3.15B79 5-pillar Nov 18, 2026
Solventum Corporation (SOLV) Named competitor$85.80 Nov 19, 2026$14.6B66 5-pillar Nov 18, 2026
The Cooper Companies, Inc. (COO) Named competitor$60.33 Nov 19, 2026$11.5B40 5-pillar Nov 18, 2026
10x Genomics, Inc. (TXG) Same industry, near in market value$57.07 Nov 18, 2026$7.51B38 5-pillar Nov 18, 2026
Certara, Inc. (CERT) Same industry, near in market value$10.68 Nov 19, 2026$1.63B37 5-pillar Nov 18, 2026
Viatris Inc. (VTRS) Named competitor$19.88 Nov 19, 2026$22.8B35 5-pillar Nov 18, 2026
HeartFlow, Inc. (HTFL) Same industry, near in market value$45.89 Nov 18, 2026$4.03B35 5-pillar Nov 18, 2026
Guardant Health, Inc. (GH) Named competitor$145.14 Nov 18, 2026$19.6B34 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$23.00 – $41.00
Consensus target
$31.75
Median target
$32.50

Consensus record · Captured .

Measured against a quoted price of $29.61 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 5, 2026

Transactions
71
Identified insiders
9
Purchases
0
Sales
12
Other transactions
59

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held DOCS in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
FundsmithTerry SmithQ3 20260.10%$12.37MTrimmed −33.2% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Doximity (DOCS)?

Read these with our analysis →

Doximity Healthcare Stock: Key Questions Answered

The last 2 questions are answered from this page's own dated data, not from the research.

Why is the subscription segment so much larger than service revenue?

Subscription revenue reflects fees charged to healthcare organizations and data licensing arrangements, which are recurring and predictable. Service revenue represents marketing services and other offerings that are episodic. The subscription model generates the business durability and earnings consistency; service revenue adds optionality.

How can margins be this high if the company keeps losing estimated earnings?

Operating margins measure cash generation after costs; earnings per share reflects share dilution from equity compensation and one-time charges. The company is cash-generative and profitable by cash accounting, but equity compensation and non-cash items reduce reported net income per share.

Why did operating cash flow decline quarter-over-quarter?

The latest quarter's operating cash flow reflects timing of annual subscription billings and customer payment cycles rather than operational deterioration. Annual subscription renewals create large inflows in certain periods and smaller flows in others. The trailing-twelve-month cash conversion remains strong, and revenue growth continued.

Would a tech giant acquisition of a competitive platform be catastrophic?

New competition from scale-advantaged incumbents is the true structural risk. A Microsoft or Amazon platform feature targeting physicians would draw on existing healthcare relationships and infrastructure. Doximity's network effects and embedded workflow provide some defensibility, but pricing power would face downward pressure if credible alternatives materialized.

What is the DOCS stock price today?

The last price recorded for Doximity, Inc. (DOCS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the DOCS price target?

The analyst consensus price target for Doximity, Inc. (DOCS), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 43 figures on this page — 1 from SEC filings and earnings calls, 35 from Financial Modeling Prep (FMP), 4 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Annual revenue and net result (USD millions)
  • 1. What is Doximity (DOCS), and what does it report?: Business description; Operating cash flow by quarter (USD millions); Quarterly income statement (USD thousands)
  • 2. What do the latest results show for Doximity (DOCS)?: Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions)
  • 3. What are the financial strengths and risks for Doximity (DOCS)?: Cash, investments and debt; Trailing twelve-month ratio set; Cash against market value
  • 4. What should you watch next at Doximity (DOCS)?: Analyst revenue and earnings estimates (average); Analyst actions, most recent per firm; Cash decline over the reported window
  • 5. How does Doximity compare with its peers?: Business description; Revenue by segment; Distress and quality screens
  • FAQ: Why is the subscription segment so much larger than service revenue?: Revenue by segment; Annual revenue and net result (USD millions); Trailing twelve-month ratio set
  • FAQ: How can margins be this high if the company keeps losing estimated earnings?: Operating cash flow by quarter (USD millions); Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters
  • FAQ: Why did operating cash flow decline quarter-over-quarter?: Operating cash flow by quarter (USD millions); Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)
  • FAQ: Would a tech giant acquisition of a competitive platform be catastrophic?: Trailing twelve-month ratio set; Analyst actions, most recent per firm; Business description
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.